Kawasaki disease: the mystery continues

Related Experiment Video

Updated: Sep 30, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

J C Burns1

  • 1UCSD School of Medicine, La Jolla, CA, USA. jcburns@ucsd.edu

Minerva Pediatrica
|July 20, 2002
PubMed

Insights

Kawasaki disease (KD) is a childhood vasculitis with unknown causes and no diagnostic test. Early treatment with IVIG and aspirin significantly reduces coronary artery damage risk.

Area of Science:

  • Pediatric rheumatology
  • Vascular inflammation
  • Immunology

Background:

  • Kawasaki disease (KD) is an acute vasculitis affecting infants and young children.
  • It can lead to permanent coronary artery damage in 20-25% of untreated cases.
  • The etiology of KD remains unknown, and no specific diagnostic test exists.

Purpose of the Study:

  • To review the current understanding of Kawasaki disease.
  • To highlight diagnostic challenges and treatment efficacy.
  • To identify unanswered questions regarding KD pathogenesis and management.

Main Methods:

  • Literature review of existing research on Kawasaki disease.
  • Analysis of clinical presentation, diagnostic criteria, and treatment outcomes.
  • Discussion of current therapeutic strategies and their impact.

Main Results:

  • Kawasaki disease diagnosis is primarily clinical, lacking specific biomarkers.
  • High-dose intravenous immunoglobulin (IVIG) plus aspirin within 10 days of fever onset is highly effective.
  • Effective treatment significantly reduces the risk of coronary artery abnormalities.

Conclusions:

  • Kawasaki disease presents a diagnostic and therapeutic dilemma due to its unknown cause and potential for severe cardiovascular complications.
  • Early recognition and prompt treatment are crucial to prevent long-term sequelae.
  • Further research is needed to elucidate the underlying mechanisms and improve diagnostic accuracy.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...